Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Lorazepam
Arrow Generics Ltd
N05BA06
Lorazepam
1mg
Oral tablet
Oral
Schedule 4 (CD Benz)
Valid as a prescribable product
BNF: 04010200
Product: MA Holder: GENETHICS EUROPE PL No.: 42976/0034 & 0035 Pack Size: ALL PACK Livery: GENETHICS EUROPE Manufacturer: - Market: UK Component: LEAFLET Dimensions: 148 X 297 MM Created By: DTAWDE Artwork Code: GE0034-0035/O/PIL1/GE2 Bar Code: - Font Type: ARIAL NARROW Font Size: 8.2 PT Printing Colours: Non-Printing Colours: Final Preparation Date For Submission: 01/08/2018 Packing Site Technical Approval: 00/00/0000 Authority Approval Date: 00/00/0000 Latest Implementation Deadline: 00/00/0000 Print Proof Approval: 00/00/0000 LORAZEPAM 1 & 2.5 MG TABLETS Black Profile OTHER SIDE EFFECTS VERY COMMON (may affect more than 1 in 10 people): Daytime drowsiness. COMMON (may affect around 1 in 100 people): Dizziness, poor muscle control, muscle weakness, fatigue. RARE (may affect around 1 in 1,000 people): Depression, numbed emotions, difficulty controlling urges and impulses to speak, act or show emotions, a feeling of well-being for no reason, appetite changes, sleep problems, changes in sex drive, decreased orgasm, headache, slurred speech, memory loss or forgetfulness, problems with vision including double vision or blurred vision, worsening of sleep apnoea (e.g. loud snoring, restlessness and choking/gasping during the night), breathing difficulties, stomach upsets, nausea, constipation, changes in the amount of saliva in the mouth, skin problems such as rashes and inflammation, erectile dysfunction, blood or liver function changes, low blood pressure or low body temperature. VERY RARE (may affect around 1 in 10,000 people): Trembling or shaking. NOT KNOWN (frequency cannot be estimated from the available data: Increased risk of falling. REPORTING OF SIDE EFFECTS If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for ‘MHRA Yellow Card’ in the Google Play or Apple App Store. By reporting side effects yo Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lorazepam 1mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Lorazepam 1mg tablets _ Each tablet contains 1mg lorazepam. Excipient with known effect: _Lorazepam 1mg tablets _ Each tablet contains 68.82mg lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet _Lorazepam 1mg tablets _ white, round, flat, bevelled, scored tablets, with “1.0” inscription, diameter between 6.3 mm – 6.5 mm, thickness between 2.4 mm – 2.6 mm, theoretical weight 106.5 mg. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS FOR SHORT TERM (2-4 weeks only) USE (adults only) • Symptomatic relief of anxiety that is severe, disabling or subjecting the individual to unacceptable distress occurring alone or in association with insomnia or short- term psychometric, organic or psychotic illness. AS PREMEDICATION (adults and children 6 years and above) Before operative dentistry and general surgery NOT FOR USE • Long term (i.e. longer than 4 weeks) • For mild/moderate anxiety • For insomnia or anxiety in children 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Treatment to be given: • Under close medical supervision • At the lowest effective dose • For the shortest possible duration (not exceeding 4 weeks) Doses should be individualised Extension of use should not take place without further clinical evaluation Chronic use not recommended (little is known of the long term safety and efficacy; potential for dependence–see section 4.4). When treatment is started the patient should be informed that • treatment will be of limited duration • the dosage will be progressively decreased • there is a possibility of rebound phenomena Dosage: _ _ _Adults: _ Anxiety: 1-4mg daily in divided doses. Insomnia: 1-2mg before retiring Premedication before operative dentistry or general surgery: 2-3mg the night before operation 2-4mg one to two hours before the procedure _Elderly: _ The Read the complete document